Artificial Intelligence in POCUS: The Vanguard of Technology in COVID-19 Pandemic

Abstract

The creation of intelligent software or system, machine learning, and deep learning technologies are the integral components of artificial intelligence. Point-of-care ultrasound involves the bedside use of ultrasound to answer specific diagnostic questions and to assess real-time physiologic responses to treatment. This article provides insight into the pearls and pitfalls of artificial intelligence in point-of-care ultrasound for the coronavirus disease 2019 pandemic.

Keywords

lung ultrasound - B line - artificial intelligence - COVID-19 - algorithms

Publication History

Publication Date:
06 November 2020 (online)

• References

• 1 Zhu N, Zhang D, Wang W. et al. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
• 2 Kanne JP, Chest CT. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology 2020; 295 (01) 16-17
• 3 Clerkin KJ, Fried JA, Raikhelkar J. et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation 2020; 141 (20) 1648-1655
• 4 Peng QY, Wang XT, Zhang LN. Chinese Critical Care Ultrasound Study Group (CCUSG). Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. Intensive Care Med 2020; 46 (05) 849-850
• 5 Lichtenstein D. Lung ultrasound in the critically ill. In: 2004 Yearbook of Intensive Care and Emergency Medicine. Berlin, Germany: Springer-Verlag; 2004: 625-644
• 6 Huang, Y, Wang S, Liu Y et al. A preliminary study on the ultrasonic manifestations of peripulmonary lesions of non-critical novel coronavirus pneumonia (COVID-19). SSRN 2020. Epub 28 February
• 7 Soldati G, Smargiassi A, Inchingolo R. et al. Is there a role for lung ultrasound during the COVID-19 pandemic?. J Ultrasound Med 2020; 39 (07) 1459-1462
• 8 Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062
• 9 Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020; 17 (05) 259-260
• 10 Oudit GY, Kassiri Z, Jiang C. et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 2009; 39 (07) 618-625
• 11 Peng Q-Y, Wang X-T, Zhang L-N. Chinese Critical Care Ultrasound Study Group (CCUSG). Using echocardiography to guide the treatment of novel coronavirus pneumonia. Crit Care 2020; 24 (01) 143
• 12 Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD). https://www.fda.gov/media/122535/ downloads. Accessed Aug 14, 2020
• 13 https://www.gehealthcare.com/products/ultrasound/ultrasound-transducers#generalcare. Accessed Aug 14, 2020
• 14 Buonsenso D, Pata D, Chiaretti A. COVID-19 outbreak: less stethoscope, more ultrasound. Lancet Respir Med 2020; 8 (05) e27 DOI: 10.1016/S2213-2600(20)30120-X.
• 15 Brusasco C, Santori G, Bruzzo E. et al. Quantitative lung ultrasonography: a putative new algorithm for automatic detection and quantification of B-lines. Crit Care 2019; 23 (01) 288
• 16 Shaikh F, Awan O, Friedman O, Qadir THN, Barjaktarevic I. Measuring the accuracy of cardiac output using POCUS: the introduction of artificial intelligence into routine care. Am J Respir Crit Care Med 2020; 201: A1775
• 17 Venue Go R2 Technical Product Claims Document (DOC2199650)
• 18 Cheung JCH, Lam KN. POCUS in COVID-19: pearls and pitfalls. Lancet Respir Med 2020; 8 (05) e34 DOI: 10.1016/S22132600(20)301661.